glp-1 medications long term side effects The Promise of Weight-Loss Drugs Keeps Growing, Here's What's Coming Next | by Earl Cotten | Newsarticulated | May, 2026 GLP-1 diabetes and weight-loss drug

Most evidence to date reflects changes in downstream or adaptive pathways, such as inflammation, mitochondrial function, and metabolic regulation, rather than direct modification of the primary sources of molecular damage

The current trend of uncontrolled use of these medications may obscure potential harms to patients

As healthcare providers, policymakers, and citizens, we must advocate for the preservation of Medicaid coverage for obesity medications

Lau D, Gamble JM

Once the medication was ordered, I was sent an email with tracking information

Psychological aspects of switching receive less attention than physical effects but significantly impact experiences